HLEC(Lens)人晶狀體上
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/2/11 15:46:48
- 訪問次數(shù) 28
聯(lián)系方式:陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!
產(chǎn)品名稱:HLEC(Lens)人晶狀體上皮細(xì)胞、HLEC(Lens)人晶狀體上皮細(xì)胞、HLEC(Lens)人晶狀體上皮細(xì)胞、HLEC(Lens)人晶狀體上皮細(xì)胞;
Purpose: Trapeziometacarpal osteoarthritis (TMC-OA) is a prevalent hand disorder affecting a growing number of people worldwide. While a multidisciplinary approach might provide additional advantages, the analgesic and anti-inflammatory role of intra-articular oxygen-ozone (O2O3) injections combined with physical therapy is still unknown. To assess the impact of a multimodal therapeutic approach combining O2O3 injections with physical therapy in patients with TMC-OA.
Materials and methods: A prospective open-label study conducted in the Physical and Rehabilitation Medicine Unit of the Renato Dulbecco University Hospital of Catanzaro. We assessed patients with TMC-OA who had not responded to standard medical therapy. Participants received O2O3 therapy and targeted physical therapy for 4?weeks. Pain relief, muscle strength, and physical functioning were assessed at baseline and after 4, 12 and 24?weeks (respectively T0, T1, T2, and T3).
Results: Seventeen patients with a mean age of 67.1?±?6.1?years were included in the study. Short-term improvements in pain intensity were o9plerved (T0: 6.221?±?1.514; T1: 3.172?±?1.1451; p .001) and were maintained over a 24-week follow-up period (T0: 6.221?±?1.514; T3: 4.393?±?1.438; p: 0.006). Significant changes were reported also in terms of muscle strength and physical functioning. O2O3 therapy was well-tolerated with no adverse effects.
Conclusions: A combination of O2O3 injections and physical therapy might be considered in patients with TMC-OA. Further investigation is warranted to assess the effectiveness of O2O3 therapy in managing TMC-OA.